ArticleNature communications2025
Interplay of ECM organization, ROCK signaling, and cell polarity drives mesothelium formation and lung growth.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The mechanisms regulating organ size remain poorly understood. Here, we show that FREM2 is a critical modulator of lung size. Frem2 mutant mice exhibit defects in the formation of elastic fibers around mesothelial cells, which compromises phosphorylated myosin light chain (pMLC) signaling and mesothelial cell polarization, leading to lung growth inhibition. These processes are regulated in part through inhibition of p38-mediated upregulation of matrix metalloproteinase-2, as pharmacological decrease of p38 phosphorylation or MMP activity partially attenuates the Frem2 mutant lung phenotypes. Disruption of ROCK function also leads to defects in elastic fiber organization and mesothelial cell polarity, while inhibition of Vangl2-regulated mesothelial cell polarity causes defects in pMLC abundance and elastic fiber structure. Collectively, these processes constitute a positive feedback loop to regulate lung size. Notably, Frem2 mutant mice also display defects in the formation of the mesothelium and reduced growth of other internal organs. Importantly, patients with FREM2 mutations exhibit smaller lungs. These results reveal a shared role and mechanism for the mesothelium in organ size control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.